| Nome |
# |
|
Perspectives on Neuromyelitis Optica Spectrum Disorders, the Narrative Medicine contribution to care, file c3d336d3-f1e3-4e1e-9450-e833df483bab
|
769
|
|
Didattica delle encefalopatie spongiformi, file dfe4d228-d25d-bb0a-e053-d805fe0a78d9
|
470
|
|
Cognitive-motor dual-task interference:A systematic review of neural correlates, file dfe4d229-a702-bb0a-e053-d805fe0a78d9
|
307
|
|
Neurophysiological tests in Multiple Sclerosis. A synthetic overview., file dfe4d22c-272a-bb0a-e053-d805fe0a78d9
|
67
|
|
Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany, file dfe4d22b-c9de-bb0a-e053-d805fe0a78d9
|
64
|
|
Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience, file dfe4d22b-e558-bb0a-e053-d805fe0a78d9
|
50
|
|
Post-Cerebrovascular Stroke and Early Dysphagia Assessment: A Systematic Review, file 5d25c09e-8cbe-4a7f-8fab-95f1dc1352a6
|
40
|
|
The Neutrophil-to-Lymphocyte Ratio is Related to Disease Activity in Relapsing Remitting Multiple Sclerosis, file dfe4d22b-a228-bb0a-e053-d805fe0a78d9
|
35
|
|
Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MS, file dfe4d22b-cf5f-bb0a-e053-d805fe0a78d9
|
28
|
|
Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis, file dfe4d22b-c9d9-bb0a-e053-d805fe0a78d9
|
24
|
|
Long-term safety of satralizumab in neuromyelitis optica spectrum disorder (NMOSD) from SAkuraSky and SAkuraStar, file eafd94c3-5696-4365-9d67-4bbb76f81572
|
22
|
|
A case of multiple autoimmunity complicated by SIADH, file dfe4d22b-ac3e-bb0a-e053-d805fe0a78d9
|
21
|
|
Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing–remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study), file dfe4d22b-c4a6-bb0a-e053-d805fe0a78d9
|
21
|
|
Cancer Risk and Multiple Sclerosis: Evidence From a Large Italian Cohort, file dfe4d22c-9893-bb0a-e053-d805fe0a78d9
|
21
|
|
Single incision extended video assisted transcervical thymectomy, file dfe4d22b-66cd-bb0a-e053-d805fe0a78d9
|
20
|
|
An “all-wheel drive” proposal to accelerate clinical research in common and rare neurological diseases, file dfe4d22b-7d50-bb0a-e053-d805fe0a78d9
|
19
|
|
Botulinum Toxin A for Sialorrhoea Associated with Neurological Disorders: Evaluation of the Relationship between Effect of Treatment and the Number of Glands Treated, file dfe4d22b-699b-bb0a-e053-d805fe0a78d9
|
17
|
|
Authors' Response to the Letter to the Editor Regarding: A Comprehensive Review on Copemyl®, file dfe4d22b-d139-bb0a-e053-d805fe0a78d9
|
17
|
|
Italian Validation of the 12-Item Multiple Sclerosis Walking Scale, file dfe4d22a-736d-bb0a-e053-d805fe0a78d9
|
16
|
|
Participant perspectives of a home-based palliative approach for people with severe multiple sclerosis: A qualitative study, file dfe4d22c-1a30-bb0a-e053-d805fe0a78d9
|
16
|
|
Home-based palliative approach for people with severe multiple sclerosi and their carers: study protocol for a randomized controlled trial, file dfe4d22b-6c94-bb0a-e053-d805fe0a78d9
|
15
|
|
Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study), file dfe4d22b-e60e-bb0a-e053-d805fe0a78d9
|
15
|
|
Randomized controlled trial of a home-based palliative approach for people with severe multiple sclerosis, file dfe4d229-a704-bb0a-e053-d805fe0a78d9
|
14
|
|
Gonadal Steroids and Sperm Quality in a Cohort of Relapsing Remitting Multiple Sclerosis: A Case-Control Study, file dfe4d22d-d229-bb0a-e053-d805fe0a78d9
|
14
|
|
The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study, file ec087700-a3a0-4103-910f-9d4aacf5cd0a
|
14
|
|
Primary cerebral vasculitis, file dfe4d22b-6582-bb0a-e053-d805fe0a78d9
|
13
|
|
Pesticide exposure assessed through agricultural crop proximity and risk of amyotrophic lateral sclerosis, file dfe4d22b-e41f-bb0a-e053-d805fe0a78d9
|
13
|
|
Beyond disease: Happiness, goals, and meanings among persons with multiple sclerosis and their caregivers, file dfe4d229-a985-bb0a-e053-d805fe0a78d9
|
12
|
|
Offspring Number Does Not Influence Reaching the Disability's Milestones in Multiple Sclerosis: A Seven-Year Follow-Up Study, file dfe4d22a-e87b-bb0a-e053-d805fe0a78d9
|
12
|
|
May baseline JCV status influence the MS clinical evolution during Natalizumab treatment? Evidence from a multicenter-2 years-prospective study, file dfe4d22b-c669-bb0a-e053-d805fe0a78d9
|
12
|
|
Inpatient versus outpatient rehabilitation for multiple sclerosis patients: effects on disability and quality of life, file dfe4d22b-c6dc-bb0a-e053-d805fe0a78d9
|
12
|
|
The Italian multiple sclerosis register, file dfe4d22c-2996-bb0a-e053-d805fe0a78d9
|
12
|
|
Depressive symptoms correlate with disability and disease course in multiple sclerosis patients: An Italian multi-center study using the Beck Depression Inventory, file dfe4d22c-2ffa-bb0a-e053-d805fe0a78d9
|
12
|
|
Efficacy and safety of extracranial vein angioplasty in multiple sclerosis: A randomized clinical trial, file dfe4d229-954b-bb0a-e053-d805fe0a78d9
|
11
|
|
Clinical and Lifestyle Factors and Risk of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study, file dfe4d22a-11c9-bb0a-e053-d805fe0a78d9
|
11
|
|
Retinal Nerve Fiber Layer Thickness and Higher Relapse Frequency May Predict Poor Recovery after Optic Neuritis in MS Patients, file dfe4d22b-05aa-bb0a-e053-d805fe0a78d9
|
11
|
|
Natalizumab in the pediatric MS population:results of the Italian registry, file dfe4d22b-c9d8-bb0a-e053-d805fe0a78d9
|
11
|
|
Wegener’s Granulomatosis Presenting as An Intracranial Hypertension Syndrome Treated with High Dose of Cyclophosphamide, file dfe4d22c-8623-bb0a-e053-d805fe0a78d9
|
11
|
|
Effects of Nintendo Wii Fit® balance exercise program on physical abilities and quality of life in Multiple Sclerosis patients, file 4b3ba7cd-bbc5-4222-a88f-cfcdcd542352
|
10
|
|
Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register, file 83428b5c-c451-4494-b905-3928e9024ae7
|
10
|
|
Reliability of televisits for patients with mild relapsing-remitting multiple sclerosis in the COVID-19 era, file c528ce0f-b8bd-465e-881b-58b7bcb3f313
|
10
|
|
Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis Patients: Monocentric Case Series and Systematic Review of the Literature, file d2a47064-7ba0-45ff-873c-5b1fd343c82f
|
10
|
|
Sexual Dysfunction in People with Multiple Sclerosis: The Role of Disease Severity, Illness Perception, and Depression, file da37e592-f467-4ca4-8daf-2f5fcb4e9209
|
10
|
|
Changes in magnetic resonance imaging isease measures over 3 years in mildly disabled patients with relapsing-remitting multiple sclerosis receiving interferon β-1a in the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) study, file dfe4d229-5308-bb0a-e053-d805fe0a78d9
|
10
|
|
Multiple sclerosis: Getting personal with induced pluripotent stem cells, file dfe4d22a-9a00-bb0a-e053-d805fe0a78d9
|
10
|
|
Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients, file dfe4d22c-28e0-bb0a-e053-d805fe0a78d9
|
10
|
|
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis, file dfe4d22e-8279-bb0a-e053-d805fe0a78d9
|
10
|
|
Immunosuppression in relapsing remitting multiple sclerosis: moving towards personalized treatment, file e71bb79d-812f-4009-b194-06f26cfecb62
|
10
|
|
Patients with multiple sclerosis: a burden and cost of illness study, file ba9f6171-7c68-42d2-b768-ae5e26735534
|
9
|
|
Discontinuation of teriflunomide and dimethyl fumarate in a large Italian multicentre population: a 24-month real-world experience, file dfe4d229-aef9-bb0a-e053-d805fe0a78d9
|
9
|
|
Environmental and Occupational Risk Factors of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study, file dfe4d22a-eecd-bb0a-e053-d805fe0a78d9
|
9
|
|
Patients with paediatric-onset multiple sclerosis are at higher risk of cognitive impairment in adulthood: An Italian collaborative study, file dfe4d22b-dbe1-bb0a-e053-d805fe0a78d9
|
9
|
|
A Personalized Approach in Progressive Multiple Sclerosis: The Current Status of Disease Modifying Therapies (DMTs) and Future Perspectives, file dfe4d22c-7fdc-bb0a-e053-d805fe0a78d9
|
9
|
|
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies, file f38e1e53-beb5-4984-8bce-87f2fa91d0d4
|
9
|
|
Early use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinion, file f82732f3-a7d8-4b8a-99ea-1aaa5da4bfbe
|
9
|
|
Clinical features of Sjogren's syndrome in patients with multiple sclerosis, file 0e8546f2-562c-40f0-9798-6620a41240d3
|
8
|
|
Subcutaneous Interferon B-1a May Protect against Cognitive Impairment in Patients with Relapsing-Remitting Multiple Sclerosis: 5 Year Follow-up of the COGIMUS Study, file 143caf57-2df5-4048-ad75-23930280a6ea
|
8
|
|
Sexual dysfunction in multiple sclerosis: The impact of different MSISQ-19 cut-offs on prevalence and associated risk factors, file 7b736b18-3fb5-4a99-b554-a94acd99779b
|
8
|
|
Development of a Short Version of MSQOL-54 Using Factor Analysis and Item Response Theory, file c81c1d86-e125-47fe-9ea7-32ed4a97856a
|
8
|
|
Status Update and Interim Results from the Asymptomatic Carotid Surgery Trial-2 (ACST-2), file dfe4d227-026b-bb0a-e053-d805fe0a78d9
|
8
|
|
Blood levels of transforming growth factor-beta 1 (TGF-beta 1) are elevated in both relapsing remitting and chronic progressive multiple sclerosis (MS) patients and are further augmented by treatment with interferon-beta 1b (IFN-beta 1b), file dfe4d227-279b-bb0a-e053-d805fe0a78d9
|
8
|
|
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity, file dfe4d229-a700-bb0a-e053-d805fe0a78d9
|
8
|
|
Health Authorities Data Collection of THC:CBD Oromucosal Spray (L'Agenzia Italiana del Farmaco Web Registry): Figures after 1.5 Years, file dfe4d22a-bc0e-bb0a-e053-d805fe0a78d9
|
8
|
|
Disability may influence patient willingness to partecipate in decision making on first-line therapy in multiple sclerosis, file dfe4d22a-e87c-bb0a-e053-d805fe0a78d9
|
8
|
|
Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register, file dfe4d22b-a3ca-bb0a-e053-d805fe0a78d9
|
8
|
|
Patient and caregiver involvement in the formulation of guideline questions: findings from the European Academy of Neurology guideline on palliative care of people with severe multiple sclerosis, file dfe4d22b-c9dd-bb0a-e053-d805fe0a78d9
|
8
|
|
A Comprehensive Review on Copemyl(®), file dfe4d22b-ff6a-bb0a-e053-d805fe0a78d9
|
8
|
|
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study, file e0fca6d3-d4db-4709-a9de-f6d32682609e
|
8
|
|
Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study, file 2a9cd0ee-fb63-481d-bc07-708864e88b5e
|
7
|
|
Correction to: Prevalence and predictors of bowel dysfunction in a large multiple sclerosis outpatient population: an Italian multicenter study, file 301a1ba5-91a3-403f-9745-f314a37b2aac
|
7
|
|
Clinical and patient determinants of changing therapy in relapsing-remitting multiple sclerosis (SWITCH study), file 3a161645-3098-4931-b2aa-2a67954221fd
|
7
|
|
Treatment satisfaction, safety, and tolerability of cladribine tablets in patients with highly active relapsing multiple sclerosis: CLARIFY-MS study 6-month interim analysis, file 5f09fd13-f3a2-4d62-a5c8-a653d5061679
|
7
|
|
Immunological Subsets Characterization in Newly Diagnosed Relapsing–Remitting Multiple Sclerosis, file bdbf06d1-b031-47e5-a571-d5794efb28e2
|
7
|
|
Natalizumab administration in multiple sclerosis patients during active SARS-CoV-2 infection: a case series, file bf71bb0a-5584-42e6-bb63-11a40c7ba33c
|
7
|
|
Variable effects of cyclophosphamide in rodent models of experimental allergic encephalomyelitis, file dfe4d226-fc53-bb0a-e053-d805fe0a78d9
|
7
|
|
Fattori ambientali di rischio della sclerosi laterale amiotrofica: uno studio caso-controllo di popolazione basato su questionari anamnestici., file dfe4d227-693b-bb0a-e053-d805fe0a78d9
|
7
|
|
Epilepsy and multiple sclerosis in Sicily: a population-based study, file dfe4d227-aafc-bb0a-e053-d805fe0a78d9
|
7
|
|
Environmental and occupational risk factors of amyotrophic lateral sclerosis: a population-based case control study, file dfe4d228-d1b9-bb0a-e053-d805fe0a78d9
|
7
|
|
Association Between the Neurogenic Bladder Symptom Score and Urodynamic Examination in Multiple Sclerosis Patients With Lower Urinary Tract Dysfunction, file dfe4d22a-aa7f-bb0a-e053-d805fe0a78d9
|
7
|
|
Clinical and radiologic rebound after discontinuation of natalizumab therapy in a highly active multiple sclerosis patient was not halted by dimethyl-fumarate: a case report, file dfe4d22b-37a5-bb0a-e053-d805fe0a78d9
|
7
|
|
Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes, file dfe4d22d-cee8-bb0a-e053-d805fe0a78d9
|
7
|
|
Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study, file 3b3c8526-3dc1-4011-bbab-8536f3f7cc97
|
6
|
|
Paediatric multiple sclerosis: A scoping review of patients’ and parents’ perspectives, file 72c65c3d-59b5-4338-b441-45c39ebc3e99
|
6
|
|
Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis, file 79b61915-9441-4579-85ee-62817f2764b8
|
6
|
|
A real-world evidence study of nabiximols in multiple sclerosis patients with resistant spasticity: Analysis in relation to the newly described 'spasticity-plus syndrome', file 7c1800dd-fd08-405e-8f62-7bdb573fdf8a
|
6
|
|
Rituximab for the treatment of multiple sclerosis: a review, file 83a060c8-348e-42e4-a7fd-3ca410bc3b70
|
6
|
|
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis, file 90fb5f8f-2819-4da5-bcf5-dcea1c2fef16
|
6
|
|
Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry, file 9941648e-f352-466d-8f35-ed143ed3458b
|
6
|
|
Multiple Sclerosis and CCSVI: A Population-Based Case Control Study, file b3f74ec4-1701-4836-a201-fe829009c8d8
|
6
|
|
Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis, file b9179048-9402-4999-8d43-d948a5414984
|
6
|
|
Multiple Sclerosis in the Mount Etna region: possible role of volcanogenic trace elements, file dfe4d226-ffcb-bb0a-e053-d805fe0a78d9
|
6
|
|
Negative prognostic impact of MRI spinal lesion in the early stages of relapsing-remitting multiple sclerosis, file dfe4d22a-bc0d-bb0a-e053-d805fe0a78d9
|
6
|
|
Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder, file dfe4d22b-9696-bb0a-e053-d805fe0a78d9
|
6
|
|
Examining the validity of the multiple-sclerosis walking scale-12 with Rasch analysis: Results from an Italian study, file dfe4d22b-a3c7-bb0a-e053-d805fe0a78d9
|
6
|
|
Cardiovascular autonomic individual profile of relapsing-remitting multiple sclerosis patients and risk of extending cardiac monitoring after first dose fingolimod, file dfe4d22b-a3c9-bb0a-e053-d805fe0a78d9
|
6
|
|
The Cost-effectiveness of Sativex®: The Italian Experience Based on " in Resistant Multiple Sclerosis Spasticity: Discontinuation Study in a Large Population of Italian Patients, SA.FE. Study", file dfe4d22b-c9e2-bb0a-e053-d805fe0a78d9
|
6
|
|
eMSQOL-29: Prospective validation of the abbreviated, electronic version of MSQOL-54, file dfe4d22b-d0b7-bb0a-e053-d805fe0a78d9
|
6
|
|
6. Efficacy of a computer-assisted cognitive rehabilitation protocol on walking in Parkinson's disease patients with freezing of gait: a pilot study, file dfe4d22c-6254-bb0a-e053-d805fe0a78d9
|
6
|
|
Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy, file dfe4d22e-5fc7-bb0a-e053-d805fe0a78d9
|
6
|
|
A group resilience training program for people with multiple sclerosis: Study protocol of a multi-centre cluster-randomized controlled trial (multi-READY for MS), file f94cff21-abd2-445c-b599-04ed3ab7e1c7
|
6
|
| Totale |
2.741 |